All these most recent models strongly argue in favor of a disease mechanism in C9-FTD/ALS resulting from reduced C9ORF72, synergizing with repeat-dependent gain of toxicity. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.